NCT04633265View on ClinicalTrials.gov

ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy.

NACompletedINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

January 10, 2018

Primary Completion Date

March 31, 2021

Study Completion Date

March 31, 2021

Conditions

Atrial Fibrillation

Interventions

DEVICE

ECG-I Mapping of Atrial Fibrillation

Catheter ablation of Atrial Fibrillation guided by ECG-I

Trial Locations (1)

EC1A 7BE

Barts Heart Centre, London

All Listed Sponsors

lead

Barts & The London NHS Trust

OTHER

NCT04633265 - ECG-I Targeted Ablation for Persistent AF Not Responding to Pulmonary Vein Isolation Results of a Two Staged Strategy. | Biotech Hunter | Biotech Hunter